SCHEMBL5439262

SCHEMBL5439262

COc1ccc2c(CCl)csc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 5/20 0.44
MTNR1B P49286 4/20 0.44
DYRK1A Q13627 1/20 0.43
ALDH1A1 P00352 4/20 0.43
MAPT P10636 4/20 0.43
HSD17B10 Q99714 1/20 0.43
GFER P55789 1/20 0.42
KDM4E B2RXH2 4/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
PPARG P37231 2/20 0.40
PRNP P04156 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
MAPK10 P53779 1/20 0.40
NCOA2 Q15596 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
MIF P14174 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839987 0.83 CYP2A6 (0.53) MTNR1AMTNR1BDYRK1AALDH1A1MAPT
SCHEMBL5541597 0.82 MTNR1A (0.49) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL8587828 0.81 TAAR1 (0.53) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL5443958 0.80 MTNR1A (0.48) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL2878482 0.78 PPARD (0.57) MTNR1AMTNR1BHSD17B10KDM4EPPARG
SCHEMBL10663910 0.78 HTR2A (0.55)
SCHEMBL5640485 0.78 ALDH1A1 (0.54) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL10663900 0.78 MTNR1A (0.55) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL10470119 0.78 MTNR1A (0.52) MTNR1AMTNR1BALDH1A1MAPTHSD17B10
SCHEMBL29768596 0.77 TSHR (0.46) MTNR1AMTNR1BALDH1A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476455-B2 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2013-07-02 US disclosed
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them LABORATOIRE THERAMEX (MC) 2007-05-17 US disclosed
EP-1694650-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2006-08-30 EP disclosed
WO-2005058842-A1 1-N-PHENYL-AMINO-1H-IMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATOIRE THERAMEX (MC) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112009-A1 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them H1-0, H1-5, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MTNR1A 185/4885MTNR1B 79/4885DYRK1A 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.